Mana Capital LLC - 25 Oct 2022 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Oct 2022, 14:50:50 UTC
Prior SEC filing
02 Dec 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mana Capital LLC, by: Juventus, LLC, Sole Member, By: /s/ Tong Mao, Member

Key filing fact

Mana Capital LLC filed Form 4 for Cardio Diagnostics Holdings, Inc. (CDIO) on 27 Oct 2022.

Key facts

  • This page summarizes Mana Capital LLC's Form 4 filing for Cardio Diagnostics Holdings, Inc. (CDIO).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Oct 2022, 14:50.

Change

  • Previous filing in this sequence was filed on 02 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDIO transaction

Common Stock, par value $0.00001 per share

Other

Transaction value
Shares
-1,565,000
Change %
-100%
Price
Shares after
0
Date
25 Oct 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDIO transaction Derivative

Private Warrant

Other

Transaction value
Shares
-2,500,000
Change %
-100%
Price
Shares after
0
Date
25 Oct 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500,000
Exercise price
$11.50
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mana Capital LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Pursuant to the terms of the Subscription Agreement and the Second Amended and Restated Subscription Agreement and Letter Agreement between the Reporting Person and the Issuer (the "Agreements"), the Reporting Person transferred all of the common stock and private warrants it acquired in connection with the Issuer's initial public offering to permitted transferees with no consideration in compliance with the Agreements.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .